BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 20720484)

  • 21. Management of septic shock with a norepinephrine-based haemodynamic algorithm.
    Hernandez G; Bruhn A; Romero C; Javier Larrondo F; De La Fuente R; Castillo L; Bugedo G
    Resuscitation; 2005 Jul; 66(1):63-9. PubMed ID: 15993731
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Before-after study of a standardized hospital order set for the management of septic shock.
    Micek ST; Roubinian N; Heuring T; Bode M; Williams J; Harrison C; Murphy T; Prentice D; Ruoff BE; Kollef MH
    Crit Care Med; 2006 Nov; 34(11):2707-13. PubMed ID: 16943733
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low-dose hydrocortisone treatment for patients with septic shock: a pilot study comparing 3days with 7days.
    Huh JW; Choi HS; Lim CM; Koh Y; Oh YM; Shim TS; Lee SD; Kim WS; Kim DS; Hong SB
    Respirology; 2011 Oct; 16(7):1088-95. PubMed ID: 21726354
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Does body weight impact the efficacy of vasopressin therapy in the management of septic shock?
    Miller JT; Welage LS; Kraft MD; Alaniz C
    J Crit Care; 2012 Jun; 27(3):289-93. PubMed ID: 21855282
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of corticosteroids on arginine vasopressin-containing vasopressor therapy for septic shock: a case control study.
    Bauer SR; Lam SW; Cha SS; Oyen LJ
    J Crit Care; 2008 Dec; 23(4):500-6. PubMed ID: 19056013
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of norepinephrine on the outcome of septic shock.
    Martin C; Viviand X; Leone M; Thirion X
    Crit Care Med; 2000 Aug; 28(8):2758-65. PubMed ID: 10966247
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Norepinephrine or dopamine for septic shock: systematic review of randomized clinical trials.
    Vasu TS; Cavallazzi R; Hirani A; Kaplan G; Leiby B; Marik PE
    J Intensive Care Med; 2012; 27(3):172-8. PubMed ID: 21436167
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Norepinephrine plus dobutamine versus epinephrine alone for management of septic shock: a randomised trial.
    Annane D; Vignon P; Renault A; Bollaert PE; Charpentier C; Martin C; Troché G; Ricard JD; Nitenberg G; Papazian L; Azoulay E; Bellissant E;
    Lancet; 2007 Aug; 370(9588):676-84. PubMed ID: 17720019
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glibenclamide dose response in patients with septic shock: effects on norepinephrine requirements, cardiopulmonary performance, and global oxygen transport.
    Morelli A; Lange M; Ertmer C; Broeking K; Van Aken H; Orecchioni A; Rocco M; Bachetoni A; Traber DL; Landoni G; Pietropaoli P; Westphal M
    Shock; 2007 Nov; 28(5):530-5. PubMed ID: 17589379
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interaction of vasopressin infusion, corticosteroid treatment, and mortality of septic shock.
    Russell JA; Walley KR; Gordon AC; Cooper DJ; Hébert PC; Singer J; Holmes CL; Mehta S; Granton JT; Storms MM; Cook DJ; Presneill JJ;
    Crit Care Med; 2009 Mar; 37(3):811-8. PubMed ID: 19237882
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Administration of the nitric oxide synthase inhibitor NG-methyl-L-arginine hydrochloride (546C88) by intravenous infusion for up to 72 hours can promote the resolution of shock in patients with severe sepsis: results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002).
    Bakker J; Grover R; McLuckie A; Holzapfel L; Andersson J; Lodato R; Watson D; Grossman S; Donaldson J; Takala J;
    Crit Care Med; 2004 Jan; 32(1):1-12. PubMed ID: 14707554
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vasopressor weaning in patients with septic shock.
    Arellano DL; Hanneman SK
    Crit Care Nurs Clin North Am; 2014 Sep; 26(3):413-25. PubMed ID: 25169693
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Norepinephrine weaning in septic shock patients by closed loop control based on fuzzy logic.
    Merouani M; Guignard B; Vincent F; Borron SW; Karoubi P; Fosse JP; Cohen Y; Clec'h C; Vicaut E; Marbeuf-Gueye C; Lapostolle F; Adnet F
    Crit Care; 2008; 12(6):R155. PubMed ID: 19068113
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparison of initial monotherapy with norepinephrine versus vasopressin for resuscitation in septic shock.
    Daley MJ; Lat I; Mieure KD; Jennings HR; Hall JB; Kress JP
    Ann Pharmacother; 2013 Mar; 47(3):301-10. PubMed ID: 23447481
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative effects of early versus delayed use of norepinephrine in resuscitated endotoxic shock.
    Sennoun N; Montemont C; Gibot S; Lacolley P; Levy B
    Crit Care Med; 2007 Jul; 35(7):1736-40. PubMed ID: 17522580
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characteristics of plasma NOx levels in severe sepsis: high interindividual variability and correlation with illness severity, but lack of correlation with cortisol levels.
    Ho JT; Chapman MJ; O'Connor S; Lam S; Edwards J; Ludbrook G; Lewis JG; Torpy DJ
    Clin Endocrinol (Oxf); 2010 Sep; 73(3):413-20. PubMed ID: 20455885
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Terlipressin facilitates transport of septic patients treated with norepinephrine.
    Klein M; Weksler N; Borer A; Koyfman L; Kesslin J; Gurman GM
    Isr Med Assoc J; 2006 Oct; 8(10):691-3. PubMed ID: 17125115
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dear vasopressin, where is your place in septic shock?
    Duenser MW; Hasibeder WR
    Crit Care; 2005 Apr; 9(2):134-5. PubMed ID: 15774061
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of Vasopressor Exposure and Mortality in Patients With Septic Shock.
    Roberts RJ; Miano TA; Hammond DA; Patel GP; Chen JT; Phillips KM; Lopez N; Kashani K; Qadir N; Cairns CB; Mathews K; Park P; Khan A; Gilmore JF; Brown ART; Tsuei B; Handzel M; Chang AL; Duggal A; Lanspa M; Herbert JT; Martinez A; Tonna J; Ammar MA; Nazer LH; Heavner M; Pender E; Chambers L; Kenes MT; Kaufman D; Downey A; Brown B; Chaykosky D; Wolff A; Smith M; Nault K; Gong MN; Sevransky JE; Lat I;
    Crit Care Med; 2020 Oct; 48(10):1445-1453. PubMed ID: 32706559
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Does change of catecholamine use improve the outcome of patients with shock admitted to intensive care unit?
    Bahloul M; Tounsi A; Ben Algia N; Chaari A; Chtara K; Dammak H; Rekik N; Ben Hamida C; Chelly H; Bouaziz M
    Am J Ther; 2014; 21(5):358-65. PubMed ID: 23584311
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.